Rhonda Farnum - May 20, 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, COMM & MEDICAL AFFAIRS
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
May 20, 2022
Transactions value $
-$28,881
Form type
4
Date filed
5/24/2022, 07:11 PM
Previous filing
Mar 2, 2022
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$19.2K -2.2K -0.66% $8.74 331K May 20, 2022 Direct F1
transaction TBPH Ordinary Shares Sale -$9.65K -1.08K -0.33% $8.93 330K May 23, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
F2 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21.